Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.42 +0.06 (+0.82%)
As of: Sep 30, 2026 · 11:30 AM EDT

Phathom Pharmaceuticals (PHAT) Total Non-Current Liabilities (2019 - 2026)

Updated

Phathom Pharmaceuticals (PHAT) reported Total Non-Current Liabilities of $667.85 million for Q2 2026, up 3.6% from $644.55 million a year earlier and up 4.6% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Phathom Pharmaceuticals posted Total Non-Current Liabilities of $693.32 million, up 11.8% from FY2024.

  • Total Non-Current Liabilities has increased for six consecutive years, with a five-year compound annual growth rate of 48.3% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $620.4 million in FY2024 (+30.1%), $476.9 million in FY2023 (+105.5%), $232.12 million in FY2022 (+111.5%) and $109.78 million in FY2021 (+13.5%).
  • Five-year quarterly Total Non-Current Liabilities spans a low of $103.51 million in Q1 2022 and a high of $693.32 million in Q4 2025.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last 24 quarters, with growth averaging 29.5% over the last eight quarters.
  • The year-over-year growth in Total Non-Current Liabilities has ranged between 2.8% (Q1 2026) and 171.9% (Q2 2022) over the last five years.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $638.58 million (Q1 2026), $693.32 million (Q4 2025) and $651.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Phathom Pharmaceuticals 588.51 Mn -51.44 Mn 59.18 Mn 667.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 667.85 Mn
Mar 31, 2026 638.58 Mn
Dec 31, 2025 693.32 Mn
Sep 30, 2025 651.32 Mn
Jun 30, 2025 644.55 Mn
Mar 31, 2025 621.08 Mn
Dec 31, 2024 620.40 Mn
Sep 30, 2024 563.41 Mn
Jun 30, 2024 542.76 Mn
Mar 31, 2024 495.30 Mn
Dec 31, 2023 476.90 Mn
Sep 30, 2023 247.27 Mn
Jun 30, 2023 239.94 Mn
Mar 31, 2023 226.71 Mn
Dec 31, 2022 232.12 Mn
Sep 30, 2022 220.85 Mn
Jun 30, 2022 213.00 Mn
Mar 31, 2022 103.51 Mn
Dec 31, 2021 109.78 Mn
Sep 30, 2021 117.40 Mn
API Access

Phathom Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PHAT&period=max&api_key=YOUR_API_KEY